Skip to main content
Menu
US

HTRF EPIgeneous Binding Domain B Detection Kit, 500 Assay Points

This biochemical assay format enables the detection of the interaction between a subset of epigenetic binding domains and modified histone sequences.

Click to copy promo code to clipboard.
img-icon-10-off-white-yellow.svg

SAVE 10% on your first Revvity.com order. Use promo code below.

HELLO10

Terms and conditions apply.

Feature Specification
Application Biochemical Enzymatic Assay
Sample Volume 120 µL

This biochemical assay format enables the detection of the interaction between a subset of epigenetic binding domains and modified histone sequences.

Click to copy promo code to clipboard.
img-icon-10-off-white-yellow.svg

SAVE 10% on your first Revvity.com order. Use promo code below.

HELLO10

Terms and conditions apply.

Product Variants
Unit Size: 500 assay points
Part #:
62BDBPEG
List Price
USD 761.35
Your online price:
Unit Size: 10,000 assay points
Part #:
62BDBPEH
List Price
USD 3,924.12
Your online price:
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption, and disposal requirements under European REACH regulations (EC 1907/2006).

Overview

The EPIgeneous Binding Domain kit series provides a simple biochemical approach to study epigenetic reader domain interactions with modified histones. All kits are based on a GST-tagged binding domain / biotin-coupled Histone peptide format, and can be run using the same add-and-read single plate protocol.

Binding Domain kit B has been successfully validated on a wide variety of readers (18), including some important therapeutic epigenetic targets.

Specifications

Application
Biochemical Enzymatic Assay
Brand
EPIgeneous
Detection Modality
HTRF
Product Group
Kit
Sample Volume
120 µL
Shipping Conditions
Shipped in Dry Ice
Target Class
Epigenetics
Technology
TR-FRET
Therapeutic Area
Metabolism/Diabetes
Neuroscience
Oncology & Inflammation
Unit Size
500 assay points

Video gallery

How it works

Assay principle

In EPIgeneous Binding Domain kit B, the GST-tagged reader domain protein binding to the biotinylated peptide substrate is detected by a conjugate mix: anti-GST Eu cryptate-labeled antibody conjugate (donor), and XL665-conjugated streptavidin (acceptor). The interaction of the reader domain with the substrate brings the donor and acceptor dyes into close proximity, and allows FRET to occur upon light excitation. The specific signal at 665 nm is inhibited when a specific compound prevents the reader domain protein from binding to its substrate.

epigenetics-how-it-works-assay-principle-epigeneous-binding-domain-kit-b-62bdbpeg-62bdbpeh

 

Analytical performance

Peptide-biotin titration - UHRF1/ histone H3 peptide interaction

The validation of the EPIgeneous binding Domain B assay was performed using the Tudor Domain UHRF1 binding to [Lys(9)Me3] H3(1-21) peptide. The GST-UHRF1 concentration was fixed at 5 nM while the peptide-biotin was serially diluted.

The HTRF signal was proportional to the specific interaction measured between GST-UHRF1 and peptide-biotin.

The 2nM Kd value was determined from this experiment using a two-site specific binding regression. A slight shift of apparent Kd is observed when DMSO% increases.

analytical-performance-binding-domain-kit-b-1
DMSO tolerance - peptide-biotin concentration optimization

The assay window slightly decreased as the DMSO percentage increased. The assay window could then be recovered by increasing the peptide-biotin concentration. The optimal peptide-biotin concentration was selected (between real Kd and EC100 obtained on the titration without DMSO) with a compromise between assay window and assay sensitivity for inhibitor studies. Note that the higher the peptide-biotin concentration, the higher the inhibitor IC50. For further study of inhibitors, 1% DMSO and 6nM peptide-biotin conditions were applied.

Analytical-performance-binding-domain-kit-b-2
Inhibitor titration - UHRF1 by reference compound

The EPIgeneous Binding Domain B assay was performed using 4 nM peptide-biotin, 5 nM GST-UHRF1 and 1% DMSO set constant throughout the inhibitor titration. The IC50 of [Lys(9)Me3]-H3(1-21) peptide is in good agreement with published data (Rothbart et al. Nat Struct Mol Biol, 2012 - 2µM)

analytical-performance-binding-domain-kit-b-3

 

Assay validation

Validated binding domains

Three kits (A, B and C) have already been validated and fully optimized on a selection of 28 key binding domains. For non-validated reader domains, a fourth one, the Discovery Kit, enables researchers to profile which of the A, B or C kits is the best assay solution.

epigenetics-tab3-valid-binding-domains-62bddpeg

 

BINDING DOMAIN KIT A BINDING DOMAIN KIT B BINDING DOMAIN KIT C
BRD2(1) CECR2 BRD4(1/2)
BRD3(1) FALZ (BPTF) ATAD2A
BRD4(1) BRD2(2) ATAD2B
CBX 1 BRD2(1/2) BRD9
  BRD3(2) SMARCA4 (BRG1)
  BRD3(1/2) BAZ2B
  BRD4(2)  
  BRDT(1)  
  BRDT(1/2)  
  CREBBP  
  BRD1  
  BRPF3  
  TAF1L(2)  
  TAF1L(1/2)  
  TAF1(2)  
  TAF1(1/2)  
  L3MBTL1  
  UHRF1  

 

 

Resources

Are you looking for resources, click on the resource type to explore further.

1-2 of 2 Resources
Brochure Icon
Brochure
HTRF assays and reagents catalog

Discover the versatility and precision of Homogeneous Time-Resolved Fluorescence (HTRF) technology. Our HTRF portfolio offers a...

Guide Icon
Guide
HTRF solutions, guide to major applications

This guide provides you an overview of HTRF applications in several therapeutic areas.

Scroll Icon